office (+90) 312 210 50 43
fax (+90) 312 210 79 76
lab (+90) 312 210 50 44

Home Publications

Hesna Begum Akman, Merve Oyken, Taner Tuncer, Tolga Can and Ayse Elif Erson-Bensan.3' UTR Shortening and EGF signaling: Implications for breast cancer. Hum. Mol. Genet. 2015. Online Sep.22

Akman HB, Selcuklu SD, Donoghue MT, Akhavantabasi S, Sapmaz A, Spillane C, Yakicier MC, Erson-Bensan AE. ALCAM is indirectly modulated by miR-125b in MCF7 cells. Tumour Biol. 2015 May;36(5):3511-20.

Oguz Erdogan AS, Ozdemirler N, Oyken M, Alper M, Erson-Bensan AE.ARID3B expression in primary breast cancers and breast cancer-derived cell lines.  Cell Oncol. 2014 Aug;37(4):289-96.

H. Begum Akman and A. Elif Erson-Bensan. Noncoding RNAs and Cancer. TJB. 2014;38 (6): 817-828

H. Begum Akman and A. Elif Erson-Bensan. Alternative Polyadenylation and Its Impact on Cellular Processes. MicroRNA 2014; 3(1):2-9

Akman BH, Can T, Erson-Bensan AE.Estrogen-induced upregulation and 3'-UTR shortening of CDC6. Nucleic Acids Res. 2012 Nov 1;40(21):10679-88.

Akhavantabasi S,  Sapmaz A, Tuna S, Erson-Bensan AE, miR-125b targets ARID3B in breast cancer cells. Cell Structure and Function. 2012; 37(1):27-38

Astarci E, Erson-Bensan AE, Banerjee S. MMP16 expression is downregulated by microRNA-146a in spontaneously differentiating Caco-2 cells. Dev Growth Differ. 2012; 54(2):216-26

 Ozek NS, Tuna S, Erson-Bensan AE, Severcan F. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy. Analyst. 2010 Dec 15; 135(12):3094-102.

Keller JA, Erson-Bensan AE and Petty EM, Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer?, Cancer Biol Ther.2010 Nov 6;10(9) 942-944

Akhavantabasi S, Akman HB, Sapmaz A, Keller J, Petty EM, Erson AE, USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers. Mamm Genome. 2010 Aug;21(7-8):388-97 

 Erson AE, Petty EM miRNAs and cancer: New research developments and potential clinical applications, Cancer Biology and Therapy, 2009 Dec; 8 (24): 2317 – 2322

Selcuklu SD, Yakicier MC, Erson AE. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions. Cancer Genet Cytogenet. 2009 Feb; 189 (1):15-23.

Sukas S, Erson AE, Sert C, Kulah H, A parylene based double-channel micro-electrophoresis system for rapid mutation detection via heteroduplex analysis. Electrophoresis. 2008 Sep; 29 (18):3752-3758.

 Erson AE, Petty EM, miRNAs in disease and development. Clinical Genetics. 2008 Oct; 74(4):296-306.

Erson AE, Petty EM. CHFR-associated early G2/M checkpoint defects in breast cancer cells. Molecular Carcinogenesis. 2004 Jan, 39 (1): 26-33.

Erson AE, Niell BL, DeMers SK, Rouillard JM, Hanash SM, Petty EM. Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells. Neoplasia. 2001 Nov-Dec,3(6): 521-526.

 Bespalova IN, Van Camp G, J H Bom S, Brown DJ, Cryns K, DeWan AT, Erson AE, Flothmann K, Kunst HP, Kurnool P, Sivakumaran TA, Cremers CW, Leal SM, Burmeister M, Lesperance MM.  Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet. 2001 Oct, 10 (22): 2501-2508.

Rouillard JM, Erson AE, Kuick R, Asakawa J, Wimmer K, Muleris M, Petty EM, Hanash S. Virtual genome scan: a tool for restriction landmark-based scanning of the human genome. Genome Res. 2001 Aug, 11(8): 1453-1459.

 

 

Related resources